| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/14/1992 | WO1992001718A3 Functionally active selectin-derived peptides and ligand for gmp-140 |
| 05/14/1992 | WO1991018984A3 New antifungal preparations, process for making such preparations, process for obtaining plants with decreased susceptibility to fungi |
| 05/14/1992 | CA2095330A1 Polypeptide with kd hmfg differentiation antigen binding specificity |
| 05/14/1992 | CA2095256A1 Retroviral vectors useful for gene therapy |
| 05/14/1992 | CA2094916A1 Assembled viral particles and their use in a vaccine to rotaviral disease |
| 05/14/1992 | CA2094378A1 Development of dna probes and immunological reagents of human tumor associated antigens |
| 05/14/1992 | CA2072581A1 Method of gene transfer using retrotransposons |
| 05/14/1992 | CA2055425A1 Polypeptide, dna fragment encoding the same and process for producing the same, and enzyme inhibition process, drug composition and methods of treating using the same |
| 05/13/1992 | EP0485361A1 Pre-S gene codes peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
| 05/13/1992 | EP0484863A1 A monoclonal antibody and a method for measuring malondialdehyde-reacted low-density-lipoproteins |
| 05/13/1992 | EP0484500A1 Recombinant protein which binds to a complex viral antigen of hiv-1 |
| 05/13/1992 | EP0484452A1 Fibulin |
| 05/13/1992 | EP0484440A1 Efficient directional genetic cloning system |
| 05/13/1992 | EP0484411A1 Prevention of internal initiation |
| 05/13/1992 | EP0484380A1 Uses of interleukin-4 and method for purifying it |
| 05/13/1992 | EP0484369A1 Modified bioluminescent proteins and their use |
| 05/13/1992 | EP0448650A4 Herpes simplex virus type i expression vector |
| 05/13/1992 | EP0446299A4 Method for site-specifically incorporating unnatural amino acids into proteins |
| 05/12/1992 | US5112961 Granulocyte-macrophage colony stimulating factor |
| 05/12/1992 | US5112951 Separation of anti-metal chelate antibodies |
| 05/12/1992 | US5112950 Factor viii analog, preparation process, and pharmaceutical composition containing it |
| 05/12/1992 | US5112945 Preparation of islet amyloid polypeptides (iapp) and antibodies to iapp |
| 05/12/1992 | US5112944 Antitumor agents |
| 05/12/1992 | US5112812 Peptide preparation, a process for producing it and use of the peptide preparation |
| 05/12/1992 | US5112806 Antibiotic, mersacidin, a process for the preparation thereof and the use thereof as a pharmaceutical |
| 05/12/1992 | US5112754 Tissue plasminogen-activating factor and nonoclonal antibody |
| 05/12/1992 | US5112749 Recombinant DNA sequences for attenuated bacterium, Salmonella or Shigella and epitopes |
| 05/12/1992 | US5112748 Hybrid cells producing an antigen characteristic of the hepatitis b virus obtained from hepatocytes and established monkey cells, a process for obtaining these hybrid cells and their application to the production of the aforesaid antigen |
| 05/12/1992 | US5112606 Method of producing antibodies using colloidal metal as carrier |
| 05/12/1992 | CA1300536C Process for antifungal fermentation product and culture |
| 05/12/1992 | CA1300534C Human pancreatic elastase |
| 05/12/1992 | CA1300533C Sterol regulatory elements |
| 05/12/1992 | CA1300506C Modulation of animal cellular responses with compositions containing isoxanthopterin-8-(1'-beta-aldoglycosidyl) derivatives |
| 05/10/1992 | WO1992008495A1 Cytokine immunoconjugates |
| 05/08/1992 | EP0593757A4 Method for obtaining polypeptides in a cell-free system. |
| 05/08/1992 | CA2055145A1 Dna encoding a protein which binds to the enhancer of .alpha.-fetoprotein gene |
| 05/07/1992 | WO1992007579A1 Soluble mannose receptor peptides |
| 05/07/1992 | CA2095729A1 Soluble mannose receptor peptides |
| 05/07/1992 | CA2054791A1 Method for altering post-translational processing of tissue plasminogen activator |
| 05/06/1992 | EP0484281A2 Cyclosporins |
| 05/06/1992 | EP0484017A2 Endothelin precursors, genes and receptors |
| 05/06/1992 | EP0483961A1 Specific binding agents |
| 05/06/1992 | EP0483351A1 Soluble single chain t cell receptors |
| 05/06/1992 | EP0483281A1 Recombinant human thyroid peroxidase |
| 05/06/1992 | EP0483249A1 Method of transcriptionally modulating gene expression and of discovering chemicals capable of functioning as gene expression modulators |
| 05/06/1992 | EP0483247A1 Recombinantly produced human membrane cofactor protein (mcp) |
| 05/06/1992 | EP0483219A1 Enhancement of musculature in animals |
| 05/06/1992 | EP0461180A4 Development of a monoclonal antibody based detection system for listeria monocytogenes |
| 05/06/1992 | CN1060871A Novel onco-fetal gene, gene product and uses therefor |
| 05/06/1992 | CN1060785A Natural anti-cancer leukonuclein made from animal spleens |
| 05/05/1992 | US5110906 Derivatives of soluble T-4 |
| 05/05/1992 | US5110905 Activated Bacillus thuringienses delta-endotoxin produced by an engineered hybrid gene |
| 05/05/1992 | US5110738 Genetic engineering; hybridomas of melanoma and spleen cells |
| 05/05/1992 | US5110729 Method of producing peptides using baculovirus vectors in cultured cells |
| 05/05/1992 | CA1300053C Human interleukin-2 polypeptide derivative |
| 05/05/1992 | CA1300052C Episomal vector for the expression of selected dna fragments coding for optional polypeptides in mammalian cells and methods for the production thereof |
| 05/01/1992 | WO1992008731A2 T-cadherin adhesion molecule |
| 05/01/1992 | CA2095115A1 T-cadherin adhesion molecule |
| 04/30/1992 | WO1992007084A1 Purified cdw52-specific antibodies |
| 04/30/1992 | WO1992007083A1 Antibodies against the urokinase receptor and their use |
| 04/30/1992 | WO1992007076A1 Modified human tnfalpha (tumor necrosis factor alpha) receptor |
| 04/30/1992 | WO1992007075A1 Preparation of chimaeric antibodies using the recombinant pcr strategy |
| 04/30/1992 | WO1992007074A1 Polypeptide of a growth factor receptor family, application in the diagnosis and treatment of myeloproliferative diseases |
| 04/30/1992 | WO1992007073A1 Osteogenic peptides |
| 04/30/1992 | WO1992007071A1 Methods and applications for efficient genetic suppressor elements |
| 04/30/1992 | WO1992007002A1 A collagen binding protein as well as its preparation |
| 04/30/1992 | WO1992007001A1 Hepatitis c virus antibody |
| 04/30/1992 | WO1992006990A1 Molecular clones of hiv-1 and uses thereof |
| 04/30/1992 | WO1992006989A1 Varicella-zoster virus antigen |
| 04/30/1992 | WO1992006988A1 Method for the production of catalytic rna in bacteria |
| 04/30/1992 | WO1992006711A1 Blood coagulation protein antagonists and uses therefor |
| 04/30/1992 | WO1992006705A1 Heparin binding mitogen with homology to epidermal growth factor (egf) |
| 04/30/1992 | WO1992004448A3 Human mitochondrial nad(p)+-dependent malate enzyme |
| 04/30/1992 | CA2423998A1 Methods and applications for efficient genetic suppressor elements |
| 04/30/1992 | CA2094372A1 Blood coagulation protein antagonists and uses therefor |
| 04/30/1992 | CA2094045A1 Heparin binding mitogen with egf homology |
| 04/30/1992 | CA2093919A1 Hepatitis c virus antibody |
| 04/30/1992 | CA2071854A1 Method for the production of catalytic rna in bacteria |
| 04/30/1992 | CA2054302A1 Monoclonal antibody-containing agent |
| 04/29/1992 | EP0483115A2 Regulatory region for heterologous gene expression in yeast |
| 04/29/1992 | EP0483113A2 A method of producing an enzymatically active polypeptide analog of human Cu/Zn SOD |
| 04/29/1992 | EP0482671A1 Vaccine against varicella-zoster virus |
| 04/29/1992 | EP0482176A1 Monoclonal antibodies specific for toxin b of clostridium difficile |
| 04/29/1992 | EP0482144A1 Method for the recombinant production of hiridins and hirudin-like polypeptides |
| 04/29/1992 | EP0482124A1 Somatotropin analogs. |
| 04/29/1992 | EP0482086A1 Antagonists of gm-csf derived from the carboxyl terminus |
| 04/29/1992 | EP0482061A1 Dna coding for a polypeptide signal sequence in vaccinia virus |
| 04/29/1992 | EP0482018A1 Toxin uses |
| 04/29/1992 | EP0092574B1 Oligonucleotide therapeutic agent and methods of making same |
| 04/29/1992 | CN1060680A 重组马立克氏病病毒 Recombinant Marek's Disease Virus |
| 04/28/1992 | US5109120 Extended blood circulation life |
| 04/28/1992 | US5109119 Concentrated and equilibrated in polyoxyethylene glycol solution |
| 04/28/1992 | US5109113 Membrane anchor fusion polypeptides |
| 04/28/1992 | US5108988 Hydrogenated derivatives of antibiotic a/16686 |
| 04/28/1992 | US5108919 Dna sequences encoding yeast ubiquitin hydrolase |
| 04/28/1992 | US5108908 Process for the treatment of proteinic solutions containing pigments such as heminic groups or chlorophylls in view of their decolorization and products thus obtained |
| 04/28/1992 | US5108901 Tissue plasminogen activator having zymogenic or fibrin specific properties |
| 04/28/1992 | US5108900 For use in immunoassay to detect pesticides in foods and the environment |
| 04/28/1992 | US5108894 Recombinant dna having a nucleotide sequence coding for protein G or fragment thereof which is capable of specific bidning with immunoglobulins |
| 04/28/1992 | CA1299752C Optical decoding technique for speech recognition |